A combination of coenzyme Q10, feverfew and magnesium for migraine prophylaxis: a prospective observational study.
- 2017-08-30
- Observational · n = 68
- BMC complementary and alternative medicine 17(1)
- Angèle Guilbot
- Marie Bangratz
- Samira Ait Abdellah
- Christian Lucas
- PubMed: 28854909
- DOI: 10.1186/s12906-017-1933-7
- Moderate evidence
- Clinical
Supplementation significantly reduced the number of days with migraine headache during third month of supplementation compared to baseline phase (1.3 days ±1.5 versus 4.9 days ±2.6, p < 0.0001; n = 68 intention to treat; primary criterion).
- Effect
- Beneficial
- Effect size
- Large
- Significant
- Yes
- Dose
- 112.5 mg/day